Guiding principles for the implementation of non-animal safety assessment approaches for cosmetics: Skin sensitisation

Regulatory Toxicology and Pharmacology

Volumn 63, Issue 1, 2012, Pages 40-52

  Goebel, Carsten ^a   Aeby, Pierre ^b   Ade, Nadège ^c   Alépée, Nathalie ^c   Aptula, Aynur ^d   Araki, Daisuke ^e   Dufour, Eric ^c   Gilmour, Nicola ^d   Hibatallah, Jalila ^f   Keller, Detlef ^g   Kern, Petra ^a   Kirst, Annette ^h   Marrec Fairley, Monique ⁱ   Maxwell, Gavin ^d   Rowland, Joanna ^j   Safford, Bob ^d   Schellauf, Florian ⁱ   Schepky, Andreas ^k   Seaman, Chris ^j   Teichert, Thomas ^k   Tessier, Nicolas ^l   Teissier, Silvia ^c   Weltzien, Hans Ulrich ^m   Winkler, Petra ⁿ   Scheel, Julia ^g   more..

^a PROCTER AND GAMBLE COMPANY   (United States)

^b L'Oreal ^*  (Switzerland)

^c L ORÉAL RECHERCHE   (France)

^d UNILEVER RESEARCH   (United Kingdom)

^e Kanebo Cosmetics   (France)

^f Chanel   (France)

^g HENKEL KGAA   (Germany)

^h KAO GERMANY GMBH   (Germany)

ⁱ European Cosmetic Toiletry and Perfumery Association COLIPA   (Belgium)

^j GLAXOSMITHKLINE   (United Kingdom)

^k BEIERSDORF AG   (Germany)

^l Spincontrol (representing FEBEA)   (France)

^m NONE   (Germany)

ⁿ JOHNSON AND JOHNSON   (United States)

more..

Author keywords

Alternative methods; Cosmetics; Safety assessment; Skin sensitisation

Indexed keywords

COSMETIC; HORSERADISH PEROXIDASE; HYDROGEN PEROXIDE;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL REACTION KINETICS; COMPUTER MODEL; COMPUTER PREDICTION; CONCENTRATION RESPONSE; DRUG POTENCY; DRUG RESEARCH; DRUG SAFETY; EVALUATION RESEARCH; EVIDENCE BASED MEDICINE; FUNDING; GOLD STANDARD; HEALTH PROGRAM; IN VITRO STUDY; LOCAL LYMPH NODE ASSAY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REACTION TIME; RISK ASSESSMENT; SKIN SENSITIZATION; TOXICITY TESTING;

ANIMALIA;

EID: 84860535502     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2012.02.007     Document Type: Article

References (92)

1. Ade N., Martinozzi-Teissier S., Pallardy M., Rousset F. Activation of U937 cells by contact sensitizers: CD86 expression is independent of apoptosis. J Immunotoxicol. 2006, 3:189-197.
2. Aeby P., Ashikaga T., Bessou-Touya S., Schepky A., Gerberick F., Kern P., Marrec-Fairley M., Maxwell G., Ovigne J.M., Sakaguchi H., Reisinger K., Tailhardat M., Martinozzi-Teissier S., Winkler P. Identifying and characterizing chemical skin sensitizers without animal testing: Colipa's research and method development program. Toxicol. In Vitro 2010, 24:1465-1473.
3. Aleksik M., Thain E., Roger D., Saib Q., Davies M., Li J., Aptula A., Zazzeroni R. Reactivity profiling: covalent modification of single nucleophile peptides for skin sensitization risk assessment. Toxicol. Sci. 2009, 108:401-411.
4. Api A.M., Vey M. Implementation of the dermal sensitization quantitative risk assessment (QRA) for fragrance ingredients. Regul. Toxicol. Pharmacol. 2008, 52:53-61.
5. Aptula A.O., Roberts D.W. Mechanistic applicability domains for nonanimal-based prediction of toxicological end points: general principles and application to reactive toxicity. Chem. Res. Toxicol. 2006, 19:1097-1105.
6. Ashikaga T., Yoshida Y., Hirota M., Yoneyama K., Itagaki H., Sakaguchi H., Miyazawa M., Ito Y., Suzuki H., Toyoda H. Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLAT protocol. Toxicol. In Vitro 2006, 20:767-773.
7. Basketter D., Cockshott A., Corsini E., Gerberick G.F., Idehara K., Kimber I., Van Loveren H., Matheson J., Mehling A., Omori T., Rovida C., Sozu T., Takeyoshi M., Casati S. An evaluation of performance standards and non-radioactive endpoints for the local lymph node assay. The report and recommendations of ECVAM Workshop 65. [Review] [60 refs]. ATLA 2008, 36:243-257.
8. Basketter D.A., Blaikie L., Dearman R.J., Kimber I., Ryan C.A., Gerberick G.F., Harvey P., Evans P., White I.R., Rycroft R.J.G. Use of the local lymph node assay for the estimation of relative contact allergenic potency. Contact Dermatitis 2000, 53:344-348.
9. Basketter D.A., Clapp C., Jefferies D., Safford B., Ryan C.A., Gerberick F., Dearman R.J., Kimber I. Predictive identification of human skin sensitization thresholds. Contact Dermatitis 2005, 53:260-267.
10. Basketter D.A., Gerberick G.F., Kimber I. The local lymph node assay: current position in the regulatory classification of skin sensitizing chemicals. Cutan. Ocul. Toxicol. 2007, 26:293-301.
11. Basketter D.A., Kimber I. Updating the skin sensitization in vitro data assessment paradigm in 2009. J. Appl. Toxicol. 2009, 29:545-550.
12. Basketter D.A., Kimber I. Updating the skin sensitization in vitro data assessment paradigm in 2009 - a chemistry and QSAR perspective. J. Appl. Toxicol. 2010, 30:289.
13. Buehler E.V. Delayed contact hypersensitivity in the guinea pig. Arch. Dermatol. 1965, 91:171-175.
14. Cheeseman M.A., Machuga E.J., Bailey A.B. A tiered approach to threshold of regulation. Food Chem. Toxicol. 1999, 37:387-412.
15. Chipinda I., Ajibola R.O., Morakinyo M.K., Ruwona T.B., Simoyi R.H., Siegel P.D. Rapid and simple kinetics screening assay for electrophilic dermal sensitizers using nitrobenzenethiol. Chem. Res. Toxicol. 2010, 23:918-925.
16. Corsini E., Mitjans M., Galbiati V., Lucchi L., Galli C.L., Marinovich M. Use of IL-18 production in a human keratinocyte cell line to discriminate contact sensitizers from irritants and low molecular weight respiratory allergens. Toxicol. In Vitro 2009, 23:789-796.
17. ECETOC, 2002. Use of Human Data in Hazard Classification for Irritation and Sensitisation. ECETOC Monograph No. 32. European Centre for Ecetoxicology and Toxicology of Chemicals, Brussels, Belgium.
18. ECETOC, 2003. Contact sensitisation: Classification according to potency. Technical report No. 87.
19. Emter R., Ellis G., Natsch A. Performance of a novel keratinocyte-based reporter cell line to screen skin sensitizers in vitro. Toxicol. Appl. Pharmacol. 2010, 245:281-290.
20. Enoch S.J., Madden J.C., Cronin M.T. Identification of mechanisms of toxic action for skin sensitisation using a SMARTS pattern based approach. SAR QSAR Environ. Res. 2008, 19:555-578.
21. EU, 2006. Regulation (EC) No. 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACh), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No. 793/93 and Commission Regulation (EC) No. 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. Official Journal of the European Union. L 396.
22. EU, 2008. Regulation (EC) No. 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures. Official Journal of the European Union. 2008, 1-1354.
23. EU, 2009. Regulation (EC) No 1223/2009 of the European Parliament and of the council of 30 November 2009 on cosmetic products (recast). Official Journal of the Eurpean Union. L 342/59-209.
24. Felter S.P., Robinson M.K., Basketter D.A., Gerberick G.F. A review of the scientific basis for uncertainty factors for use in quantitative risk assessment for the induction of allergic contact dermatitis. Contact dermatitis 2002, 47:257-266.
25. Felter S.P., Ryan C.A., Basketter D.A., Gilmour N.J., Gerberick G.F. Application of the risk assessment paradigm to the induction of allergic contact dermatitis. Regul. Toxicol. Pharmacol. 2003, 37:1-10.
26. Franot C., Roberts D.W., Basketter D.A., Benezra C., Lepoittevin J.P. Structure-activity relationships for contact allergenic potential of gamma, gamma-dimethyl-gamma-butyrolactone derivatives. 2. Quantitative structure-skin sensitization relationships for alpha-substituted-alpha-methyl-gamma, gamma-dimethyl-gamma-butyrolactone s. Chem. Res. Toxicol. 1994, 7:307-312.
27. Gerberick F., Aleksic M., Basketter D., Casati S., Karlberg A.T., Kern P., Kimber I., Lepoittevin J.P., Natsch A., Ovigne J.M., Rovida C., Sakaguchi H., Schultz T. Chemical reactivity measurement and the predictive identification of skin sensitisers. Altern. Lab. Anim. 2008, 36:215-242.
28. Gerberick G.F., Robinson M.K., Felter S. Understanding fragrance allergy using an exposure-based risk assessment approach. Contact Dermatitis 2001, 45:333-440.
29. Gerberick G.F., Vassallo J.D., Bailey R.E., Chaney J.G., Morrall S.W., Lepoittevin J.P. Development of a peptide reactivity assay for screening contact allergens. Toxicol. Sci. 2004, 81:332-343.
30. Gerberick G.F., Vassallo J.D., Foertsch L.M., Price B.B., Chaney J.G., Lepoittevin J.P. Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach. Toxicol. Sci. 2007, 97:417-427.
31. Gerberick G.F., Troutman J.A., Foertsch L.M., Vassallo J.D., Quijano M., Dobson R.L., Goebel C., Lepoittevin J.P. Investigation of peptide reactivity of pro-hapten skin sensitizers using a peroxidase-peroxide oxidation system. Toxicol. Sci. 2009, 112:164-174.
32. Griem, P., Goebel, C., H., S., 2003. Proposal for a risk assessment methodology for skin sensitization based on sensitization potency data. Regul Toxicol Pharmacol 38, 269-290.
33. Hartung T., Bremer S., Casati S., Coecke S., Corvi R., Fortaner S., Gribaldo L., Halder M., Hoffmann S., Roi A.J., Prieto P., Sabbioni E., Scott L., Worth A., Zuang V. A modular approach to the ECVAM principles on test validity. Altern. Lab. Anim. 2004, 32:467-472.
34. Hooyberghs J., Schoeters E., Lambrechts N., Nelissen I., Witters H., Schoeters G., Van Den Heuvel R. A cell-based in vitro alternative to identify skin sensitizers by gene expression. Toxicol. Appl. Pharmacol. 2008, 231:103-111.
35. Illing H.P., Malmfors T., Rodenburg L. Skin sensitization and possible groupings for 'read across' for rosin based substances. Regul. Toxicol. Pharmacol. 2009, 54:234-241.
36. Johansson H., Lindstedt M., Albrekt A.S., Borrebaeck C.A. A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests. BMC Genomics. 2011, 12:399. ([Epub ahead of print]).
37. Jowsey I.R., Kligman A.M., White I.R., Goossens A., Basketter D.A. Evidence that two alkyl ester quaternary ammonium compounds lack substantial human skin-sensitizing potential. Dermatitis 2007, 18:32-39.
38. Judson P.N. Prediction of toxicity using DEREK for windows. Toxicol. Sci. 2002, 27:278.
39. Karlberg A.T., Bergstrom M.A., Borje A., Luthman K., Nilsson J.L. Allergic contact dermatitis-formation, structural requirements, and reactivity of skin sensitizers. Chem. Res. Toxicol. 2008, 21:53-69.
40. Keller D., Krauledat M., Scheel J. Feasibility study to support a Threshold of Sensitization Concern (TSC) concept in risk assessment based on human data. Arch. Toxicol. 2009, 8:1049-1060.
41. Kimber I., Basketter D.A., Butler M., Gamer A., Garrigue J.L., Gerberick G.F., Newsome C., Steiling W., Vohr H.W. Classification of contact allergens according to potency: proposals. Food Chem. Toxicol. 2003, 12:1799-1809.
42. Kotturi M.F., Scott I., Wolfe T., Peters B., Sidney J., Cheroutre H., von Herrath M.G., Buchmeier M.J., Grey H., Sette A. Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance. J. Immunol. 2008, 181:2124-2133.
43. Kroes R., Renwick A.G., Cheeseman M., Kleiner J., Mangelsdorf I., Piersma A., Schilter B., Schlatter J., van Schothorst F., Vos J.G., Wurtzen G. Structure-based thresholds of toxicological concern (TTC): guidance for application to substances present at low levels in the diet. Food. Chem. Toxicol. 2004, 42:65-83.
44. Kroeze K.L., Jurgens W.J., Doulabi B.Z., van Milligen F.J., Scheper R.J., Gibbs S. Chemokine-mediated migration of skin-derived stem cells: predominant role for CCL5/RANTES. J. Invest. Dermatol. 2009, 129:1569-1581.
45. Loveless S.E., Api A.M., Crevel R.W., Debruyne E., Gamer A., Jowsey I.R., Kern P., Kimber I., Lea L., Lloyd P., Mehmood Z., Steiling W., Veenstra G., Woolhiser M., Hennes C. Potency values from the local lymph node assay: application to classification, labelling and risk assessment. Regul. Toxicol. Pharmacol. 2010, 56:54-66.
46. Magnusson B., Kligman A.M. The identification of contact allergens by animal assay. The guinea pig maximization test. J. Invest. Dermatol. 1969, 52:268-276.
47. Martin S., Weltzien H.U. T cell recognition of haptens, a molecular view. Int. Arch. Allergy Immunol. 1994, 104:10-16.
48. Martin S.F., Esser P.R., Schmucker S., Dietz L., Naisbitt D.J., Park B.K., Vocanson M., Nicolas J.-F., Keller M., Pichler W.J., Peiser M., Luch A., Wanner R., Maggi E., Cavani A., Rustemeyer T., Richter A., Thierse H.-J., Sallusto F. T cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays. Cell. Mol. Life Sci. 2010, 24:4171-4184.
49. McKim J.M.J., Keller D.J., Gorski J.R. A new in vitro method for identifying chemical sensitizers combining peptide binding with ARE/EpRE-mediated gene expression in human skin cells. Cutan. Ocul. Toxicol. 2010, 29:171-192.
50. Mizumoto N., Kumamoto T., Robson S.C., Sevigny J., Matsue H., Enjyoji K., Takashima A. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat. Med. 2002, 8:358-365.
51. Mizumoto N., Mummert M.E., Shalhevet D., Takashima A. Keratinocyte ATP release assay for testing skin-irritating potentials of structurally diverse chemicals. J. Invest. Dermatol. 2003, 121:1066-1072.
52. Mizumoto N., Hui F., Edelbaum D., Weil M.R., Wren J.D., Shalhevet D., Matsue H., Liu L., Garner H.R., Takashima A. Differential activation profiles of multiple transcription factors during dendritic cell maturation. J. Invest. Dermatol. 2005, 124:718-724.
53. Moon J.J., Chu H.H., Pepper M., McSorley S.J., Jameson S.C., Kedl R.M., Jenkins M.K. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 2007, 27:203-213.
54. Natsch A., Emter R. Skin sensitizers induce antioxidant response element dependent genes: application to the in vitro testing of the sensitization potential of chemicals. Toxicol. Sci. 2008, 102:110-119.
55. Natsch A., Gfeller H. LC-MS-based characterization of the peptide reactivity of chemicals to improve the in vitro prediction of the skin sensitization potential. Toxicol. Sci. 2008, 106:464-478.
56. OECD. Quantitative Structure-Activity Relationships Project [(Q)SARs], 2340,en_2649_34365_33957015_1_1_1_1,00.htm. http://www.oecd.org/document/23/0.
57. OECD, 1992. OECD Guideline for the Testing of Chemicals 406: Skin Sensitisation, adopted: 17 July 1992.
58. OECD, 2004a. Guideline for the Testing of Chemicals 427: Skin absorption: in vivo method, adopted: 13 April 2004.
59. OECD, 2004b. Guideline for the Testing of Chemicals 428: Skin absorption: in vitro method, adopted: 13 April 2004.
60. OECD, 2010. OECD Guideline for the Testing of Chemicals 429: Skin Sensitisation: Local Lymphnode Assay, adopted: 22 July 2010. p. 7.
61. Ortmann B., Martin S., von Bonin A., Schiltz E., Hoschutzky H., Weltzien H.U. Synthetic peptides anchor T cell-specific TNP epitopes to MHC antigens. J. Immunol. 1992, 148:1445-1450.
62. Pease J.E., Williams T.J. Chemokines and their receptors in allergic disease. J. Allergy Clin. Immunol. 2006, 118:110-119.
63. Quayson A., Seaman C., Olson M., Guerriero F. Predictive performance of some structure activity tools for identification of dermal sensitizers in pharmaceutical operations. Toxicologist 2010, 114:384.
64. Quayson, A., Seaman, C., Olson, M., Guerriero, F., in press. A weight of evidence approach to improving SAR prediction of allergic contact dermatitis. Toxicologist.
65. Reuter H., Spieker J., Gerlach S., Engels U., Pape W., Kolbe L., Schmucker R., Wenck H., Diembeck W., Wittern K.P., Reisinger K., Schepky A.G. In vitro detection of contact allergens: development of an optimized protocol using human peripheral blood monocyte-derived dendritic cells. Toxicol. In Vitro 2011, 25:315-323.
66. Roberts D.W., Aptula A.O., Patlewicz G. Electrophilic chemistry related to skin sensitization. Reaction mechanistic applicability domain classification for a published dataset of 106 chemicals tested in the mouse local lymph node assay. Chem. Res. Toxicol. 2007, 20:44-60.
67. Roberts D.W., Patlewicz G., Kern P.S., Gerberick F., Kimber I., Dearman R.J., Ryan C.A., Basketter D.A., Aptula A.O. Mechanistic applicability domain classification of a local lymph node assay dataset for skin sensitization. Chem. Res. Toxicol. 2007, 20:1019-1030.
68. Roberts D.W., Aptula A.O., Patlewicz G. Mechanistic applicability domains for non-animal based prediction of toxicological endpoints. QSAR analysis of the schiff base applicability domain for skin sensitization. Chem. Res. Toxicol. 2006, 19:1228-1233.
69. Roberts D.W., Natsch A. High throughput kinetic profiling approach for covalent binding to peptides: application to skin sensitization potency of Michael acceptor electrophiles. Chem. Res. Toxicol. 2009, 22:592-603.
70. Roberts D.W., Aptula A.O., Patlewicz G.Y. Chemistry-based risk assessment for skin sensitization: quantitative mechanistic modeling for the S(N)Ar domain. Chem. Res. Toxicol. 2011, 24:1003-1011.
71. Roberts D.W., Basketter D.A. Quantitative structure-activity relationships: sulfonate esters in the local lymph node assay. Contact Dermatitis 2000, 42:154-161.
72. Roberts D.W., Basketter D.A. Further evaluation of the quantitative structure-activity relationship for skin-sensitizing alkyl transfer agents. Contact Dermatitis 1997, 37:107-112.
73. Roberts D.W., Goodwin B.F., Williams D.L., Jones K., Johnson A.W., Alderson J.C. Correlations between skin sensitization potential and chemical reactivity for p-nitrobenzyl compounds. Food Chem. Toxicol. 1983, 21:811-813.
74. Roberts D.W., Williams D.L. The derivation of quantitative correlations between skin sensitisation and physio-chemical parameters for alkylating agents, and their application to experimental data for sultones. J. Theor. Biol. 1982, 99:807-825.
75. Roberts D.W., Aptula A.O., Patlewicz G., Pease C. Chemical reactivity indices and mechanism-based read-across for non-animal based assessment of skin sensitisation potential. J. Appl. Toxicol. 2008, 28:443-454.
76. Rodford R., Patlewicz G., Walker J.D., Payne M.P. Quantitative structure-activity relationships for predicting skin and respiratory sensitization. Environ. Toxicol. Chem. 2003, 22:1855-1861.
77. Rousset F., Verda D., Garrigue J.L., Mariani M., Leclaire J. In vitro prediction of contact sensitivity with human cell lines. Contact Dermatitis 2002, 46:6.
78. Rulis A.M. De minimis and the Threshold of Regulation 1986, vol. 1. Lewis Publishers, Chelsea, MI.
79. Safford R.J. The dermal sensitisation threshold-A TTC approach for allergic contact dermatitis. Regul. Toxicol. Pharmacol. 2008, 51:195-200.
80. Safford R.J., Aptula A.O., Gilmour N. Refinement of the Dermal Sensitisation Threshold (DST) approach using a larger dataset and incorporating mechanistic chemistry domains. Regul. Toxicol. Pharmacol. 2011, 60:218-224.
81. Sakaguchi H., Ashikaga T., Miyazawa M., Yoshida Y., Ito Y., Yoneyama K., Hirota M., Itagaki H., Toyoda H., Suzuki H. Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT. Toxicol. In Vitro 2006, 20:774-784.
82. SCCS, 2010. (Scientific Committee on Consumer Products) The SCCS's Notes of Guidance for the Testing of Cosmetic Ingredients and their Safety Evaluation, 7th revision. 14th December 2010.
83. Schneider K., Akkan Z. Quantitative relationship between the local lymph node assay and human skin sensitization assays. Regul. Toxicol. Pharmacol. 2004, 39:245-255.
84. Schultz T.W., Yarbrough J.W., Johnson E.L. Structure-activity relationships for reactivity of carbonyl-containing compounds with glutathione. SAR QSAR Environ. Res. 2005, 16:313-322.
85. Schultz T.W., Rogers K., Aptula A.O. Read-across to rank skin sensitization potential: subcategories for the Michael acceptor domain. Contact Dermatitis. 2009, 60:21-31.
86. Spiekstra S.W., Dos Santos G.G., Scheper R.J., Gibbs S. Potential method to determine irritant potency in vitro - comparison of two reconstructed epidermal culture models with different barrier competency. Toxicol. In Vitro 2009, 23:349-355.
87. Toebak M.J., Gibbs S., Bruynzeel D.P., Scheper R.J., Rustemeyer T. Dendritic cells: biology of the skin. Contact Dermatitis 2009, 60:2-20.
88. Troutman J.A., Foertsch L.M., Kern P.S., Dai H.J., Quijano M., Dobson R.L., Lalko J.F., Lepoittevin J.P., Gerberick G.F. The incorporation of lysine into the peroxidase peptide reactivity assay for skin sensitization assessments. Toxicol. Sci 2010.
89. Vandebriel R.J., van Loveren H. Non-animal sensitization testing: state-of-the-art. Crit. Rev. Toxicol. 2010, 40:389-404.
90. Vink S.R., Mikkers J., Bouwman T., Marquart H., Kroese E.D. Use of read-across and tiered exposure assessment in risk assessment under REACH - a case study on a phase-in substance. Regul. Toxicol. Pharmacol. 2010, 58:64-71.
91. Vocanson M., Hennino A., Cluzel-Tailhardat M., Saint-Mezard P., Benetiere J., Chavagnac C., Berard F., Kaiserlian D., Nicolas J.F. CD8+ T cells are effector cells of contact dermatitis to common skin allergens in mice. J. Invest. Dermatol. 2006, 126:815-820.
92. Wang T.F., Kasting G.B., Nitsche J.M. A multiphase microscopic diffusion model for stratum corneum permeability. I. Formulation, solution, and illustrative results for representative compounds. J. Pharm. Sci. 2006, 95:620-648.